Home / Centerstage / 2016 / november / Week 4 /
South Africa initiates the HVTN 702 trial, a four-year study involving over 5,400 men and women, to test an experimental AIDS vaccine. This trial aims to make progress in the fight against HIV/AIDS by evaluating the safety and effectiveness of the vaccine candidate. The results could potentially contribute to the development of an effective HIV prevention strategy.
Tuesday, 29 November, 2016